JP2013518812A5 - - Google Patents

Download PDF

Info

Publication number
JP2013518812A5
JP2013518812A5 JP2012549078A JP2012549078A JP2013518812A5 JP 2013518812 A5 JP2013518812 A5 JP 2013518812A5 JP 2012549078 A JP2012549078 A JP 2012549078A JP 2012549078 A JP2012549078 A JP 2012549078A JP 2013518812 A5 JP2013518812 A5 JP 2013518812A5
Authority
JP
Japan
Prior art keywords
alkyl
alkenyl
aryl
halo
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012549078A
Other languages
English (en)
Japanese (ja)
Other versions
JP5887672B2 (ja
JP2013518812A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/021129 external-priority patent/WO2011088209A2/en
Publication of JP2013518812A publication Critical patent/JP2013518812A/ja
Publication of JP2013518812A5 publication Critical patent/JP2013518812A5/ja
Application granted granted Critical
Publication of JP5887672B2 publication Critical patent/JP5887672B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012549078A 2010-01-13 2011-01-13 ビタミンｄ関連化合物の１−デオキシ類似体 Expired - Fee Related JP5887672B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29474110P 2010-01-13 2010-01-13
US61/294,741 2010-01-13
PCT/US2011/021129 WO2011088209A2 (en) 2010-01-13 2011-01-13 1-deoxy analogs of vitamin d-related compounds

Related Child Applications (3)

Application Number Title Priority Date Filing Date
JP2015136522A Division JP2015212294A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136520A Division JP2016006055A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136521A Division JP2016006056A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体

Publications (3)

Publication Number Publication Date
JP2013518812A JP2013518812A (ja) 2013-05-23
JP2013518812A5 true JP2013518812A5 (enExample) 2014-03-06
JP5887672B2 JP5887672B2 (ja) 2016-03-16

Family

ID=44010128

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2012549078A Expired - Fee Related JP5887672B2 (ja) 2010-01-13 2011-01-13 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136521A Pending JP2016006056A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136520A Pending JP2016006055A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136522A Pending JP2015212294A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2015136521A Pending JP2016006056A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136520A Pending JP2016006055A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136522A Pending JP2015212294A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体

Country Status (3)

Country Link
US (3) US9775903B2 (enExample)
JP (4) JP5887672B2 (enExample)
WO (1) WO2011088209A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9775903B2 (en) * 2010-01-13 2017-10-03 Johns Hopkins University 1-deoxy analogs of 1,25-dihydroxyvitamin D3 compounds
GB2512314A (en) * 2013-03-26 2014-10-01 Kartar Singh Lalvani Statin composition
CN105348163B (zh) * 2014-08-18 2017-06-16 武汉启瑞药业有限公司 维生素d类似物及其制备方法和医药用途
WO2018230711A1 (ja) 2017-06-16 2018-12-20 学校法人同志社 ｍＴＯＲインヒビターを含む、眼の症状、障害または疾患を治療または予防するための医薬およびその応用
US20230398130A1 (en) * 2020-10-23 2023-12-14 Massachusetts Institute Of Technology Methods and compositions for differentiating stem cells
WO2025094144A1 (en) 2023-11-02 2025-05-08 Eirgen Pharma Ltd. Controlling loss of kidney function

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
DE60031666T2 (de) * 1999-04-01 2007-08-30 The Johns Hopkins University NICHT-CALCEMISCHE, TRANSKRIPTIONELL-AKTIVE, SCHWEFELHALTIGE ANALOGA VON 1-alpha, 25-DIHYDROXYVITAMIN D3 MIT ANTIPROLIFERATIVER WIRKUNG
WO2001028565A1 (en) * 1999-10-19 2001-04-26 Juichiro Nakayama Remedies for pigmentation and melanocyte proliferation inhibitors
JP2002104995A (ja) * 2000-09-29 2002-04-10 Masahiko Hosaka テロメラーゼ活性抑制剤
US7166585B2 (en) * 2001-08-22 2007-01-23 Cytochroma Inc. 24-Sulfur-substituted analogs of 1α,25-dihydroxy vitamin D3
ES2283593T3 (es) 2001-10-12 2007-11-01 Johns Hopkins University Analogos de oxima poco calcemicos de 1alfa,25-dihidroxi vitamina d3.
AU2003233735A1 (en) 2002-06-13 2003-12-31 Cytochroma Inc. 24-sulfoximine vitamin d3 compounds
TWI286554B (en) * 2002-06-27 2007-09-11 Chugai Pharmaceutical Co Ltd Ferrocene compounds and uses thereof
WO2004037781A1 (en) * 2002-10-23 2004-05-06 Leo Pharma A/S Vitamin d analogues, compositions comprising said analogues and their use
WO2004054968A2 (en) * 2002-12-18 2004-07-01 Johns Hopkins University 25-so2-substituted analogs of 1alpha, 25-dihydroxyvitamin d3 (calcitriol)
EP1883626B1 (en) * 2005-04-25 2017-10-11 OPKO Ireland Global Holdings, Ltd. Low-calcemic 16,23-diene 25-oxime analogs of 1alpha,25-dihydroxy vitamin d3
JP4882050B2 (ja) * 2006-03-15 2012-02-22 日本マイクロバイオファーマ株式会社 インデン誘導体の製造方法およびその製造中間体
JP2009532458A (ja) 2006-04-06 2009-09-10 ウイスコンシン アラムニ リサーチ ファンデーション ２−メチレン−１α−ヒドロキシ−１９，２１−ジノルビタミンＤ３類縁体およびその使用
US9775903B2 (en) * 2010-01-13 2017-10-03 Johns Hopkins University 1-deoxy analogs of 1,25-dihydroxyvitamin D3 compounds

Similar Documents

Publication Publication Date Title
JP2013518812A5 (enExample)
JP5113766B2 (ja) ビタミンｄ類似体：ｒａｋ、その方法および使用
JP2005536444A5 (enExample)
US7259143B2 (en) Method of extending the dose range of vitamin D compounds
JP2007505886A (ja) ２−メチレン−１９−ノル−ビタミンｄ誘導体及びビスホスフォネートの組み合わせを含む医薬組成物及び方法
RU2013128973A (ru) Соединения, активные в отношении кальций-чувствительных рецепторов
JP2009525980A (ja) ビタミンｄ類似体：ｎｅｌ、その方法および使用
CA2697079A1 (en) A method of extending the dose range of vitamin d compounds
US20190060456A1 (en) 1-deoxy analogs of vitamin d-related compounds
JP2019510045A5 (enExample)
Wietrzyk et al. Toxicity and antineoplastic effect of (24R)-1, 24-dihydroxyvitamin D3 (PRI-2191)
Wietrzyk et al. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model
JP5770261B2 (ja) （２０Ｓ）−２−メチレン−１９−ノル−２２−ジメチル−１α，２５−ジヒドロキシビタミンＤ３および（２０Ｒ）−２−メチレン−１９−ノル−２２−ジメチル−１α，２５−ヒドロキシビタミンＤ３
JP2007505883A (ja) ２−アルキリデン−１９−ノル−ビタミンｄ誘導体及び副甲状腺ホルモンの組合せを含んでなる医薬組成物及び方法
Brown et al. The vitamin D analog 1α, 25-dihydroxy-2β-(3-hydroxypropyloxy) vitamin D3 (eldecalcitol) is a potent regulator of calcium and phosphate metabolism
Chen et al. Novel vitamin d analogs for prostate cancer therapy
NZ555562A (en) 2-methylene-19-nor-(20R)-1alpha-hydroxy-bishomopregnacalciferol
WO2006113990B1 (en) LOW-CALCEMIC 16,23-DIENE 25-OXIME ANALOGS OF 1α ,25-DIHYDROXY VITAMIN D3
JP5652723B2 (ja) マキサカルシトールの新しい結晶形態
EP3072873B1 (en) Vitamin d analogues of pharmaceutical interest
ES2358914T3 (es) 2-metileno-19,21-dinor-1alfa-hidroxi-bishomopregnacalciferol.
Williams et al. 2-Methylene-19-nor-20 (S)-1α-hydroxy-bishomopregnacalciferol [20 (S)-2MbisP], an analog of vitamin D3 [1, 25 (OH) 2D3], does not stimulate intestinal phosphate absorption at levels previously shown to suppress parathyroid hormone
Pasquali et al. Further vitamin D analogs
JP2025065076A (ja) 筋組織カルシウム蓄積を抑制するビタミンｄ作用
WO2016191583A1 (en) 1α,25-DIHYDROXY-24,24-DIFLUORO-19-NOR-VITAMIN D3 ANALOGS AND THEIR PHARMACEUTICAL USES